Catherine M. Biggs

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Jérémie Rosain et al. · Science Immunology · 2021 · 631 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

Jean‐Laurent Casanova, Helen C. Su, Laurent Abel et al. · Cell · 2020 · 234 citations · Full text

Life Sciences, Genetics, Immunology +16

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

Danyel Lee, Jérémie Le Pen, Ahmad Yatim et al. · Science · 2022 · 167 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Qian Zhang, Andrés Pizzorno, Lisa Miorin et al. · The Journal of Experimental Medicine · 2022 · 128 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17